Open navigation
Search
Search

Select your region

Languages
  • English

David Dennis is a partner in the CMS Technology Team. He enjoys a wide range of commercial, technology and intellectual property-related work, with a particular interest in the life sciences sector.

David advises a full spectrum of clients ranging from start-ups to FTSE100 companies. His work spans a similar range, from small, initial agreements such as heads of terms and confidentiality agreements through to strategic licensing and long-term collaboration agreements. David is qualified in both England and Scotland and has worked in Edinburgh, Glasgow and London.

Relevant experience

  • “Big Six” UK utility company in relation to drafting a template agreement for procuring services.
  • A Russell Group University on its supply agreement for a radioactive tracer.
  • An award-winning oncology start-up on its key research and licensing agreements.
  • An international biopharmaceuticals company on its world-wide re-acquisition of product rights.
  • A listed UK pharma company on its co-development agreement regarding drug-resistant bacteria.
  • A “Big Pharma” company on its gene therapy collaboration and option agreement, worth over USD 300m.

Education

  • 2007 – LL.M., Glasgow University, Glasgow
  • 2006 – LL.B., Glasgow University, Glasgow

Insights by David

Freedom of Speech: do UK Universities comply with the new Act?

14 Aug 2025 8 min read

Founder Focus

25 Jun 2025 1 min read

Higher Education (Freedom of Speech) Act 2023 - what the Labour government’s implementation means for UK universities

12 May 2025 6 min read

Double booster for UK clinical trials

23 Apr 2025 4 min read
Back to top Back to top
You will now find all Law-Now content on CMS.law